NCT03610490 2025-04-17
Autologous Tumor Infiltrating Lymphocytes MDA-TIL in Treating Patients With Recurrent or Refractory Ovarian Cancer, Colorectal Cancer, or Pancreatic Ductal Adenocarcinoma
M.D. Anderson Cancer Center
Phase 2 Terminated
M.D. Anderson Cancer Center
ImmunityBio, Inc.
Fate Therapeutics
M.D. Anderson Cancer Center
Mayo Clinic
Cancer Research UK